Search
Johnson & Johnson
JNJAdd to Watchlist
269.470USD
-0.520-0.19%
Close 09-18 16:00（ET）
649.02BMarket Cap
30.84P/E TTM
After-hours 16:10 (ET)269.470USD-0.250-0.09%
After-hours 16:10 (ET)Johnson & Johnson (JNJ) Stock Price Target & Forecast
Analyst Rating
Based on 27 analysts giving stock ratings to Johnson & Johnson in the past month.
Buy
6 Strong Buy
13 Buy
8 Hold
0 Sell
0 Strong Sell
Target Price
274.134USD+1.45%
JNJ Analyst Recommendation Trends
In the current month, JNJ has received 13 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. JNJ average Analyst price target in the last month is 274.134.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
6
6
5
5
5
5
5
5
13
13
12
12
11
11
10
11
8
8
11
11
12
12
13
12
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27
27
28
28
28
28
28
28
JNJ Analyst Rating for Peer Comparison
Updated: Sep 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Amgen Inc
AMGN
4
12
18
2
1
37
Biogen Inc
BIIB
7
17
12
1
0
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Pfizer Inc
PFE
5
6
19
1
1
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Financial Forecasting
Based on analysts' estimates, JNJ EPS is projected to reach 2.562 in FY2026Q3, following reported EPS of 2.299 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
2.44
2.66
2.85
2.56
3.00
Actual
2.12
2.17
2.30
--
--
Surprise
-12.88%
-18.44%
-19.23%
--
--
FAQs
What is Johnson & Johnson's expected revenue for the next quarter?
Johnson & Johnson's expected revenue is 25.31B.
What is Johnson & Johnson's price target?
Analysts forecast that Johnson & Johnson's price target is USD 274.13, with the highest forecast at USD 320.00 and the lowest forecast at USD 170.00.
How have Johnson & JohnsonJNJ's recent earnings per share performed?
The market expectation was USD 2.30, while Johnson & JohnsonJNJ's earnings per share (EPS) for the previous quarter was USD 2.17. EPS for the next quarter is expected at USD 2.56.
What is the analyst rating for Johnson & Johnson?
Based on the ratings of Johnson & Johnson's stock from 27 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.